Virtual Visitation in Intensive Care Unit Study

Critically Ill Patients Clinical Trial

— ISEEU  

Official title:

Efficacy of Virtual Visitation in Intensive Care Unit During COVID-19 Pandemic: Randomized Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04962204
• Other study ID #: 2105-188-1224
• Status: Recruiting
• Phase: N/A
• Start date: July 6, 2021
• Est. completion date: June 30, 2022

Study information

• Verified date: October 2021
• Source: Seoul National University Hospital
• Contact: Seung-Young Oh
• Phone: +82-2-2072-3538
• Email: faun1226[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to identify the efficacy of virtual visitation in Intensive Care Unit on patients and their caregivers during COVID-19 Pandemic.

Description:

After being informed about the study, all patients who meet the eligibility requirements will be randomized in a 1:1 ratio to intervention group (Virtual visitation once a day) or Control group (Phone interviews once a day).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: June 30, 2022
• Est. primary completion date: March 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients who are expected to stay in the intensive care unit for more than 48 hours

• Patients with a RASS score of -2 or higher

Exclusion Criteria:

• Patients who discharge or die within 48 hours of admission to ICU

Related Conditions & MeSH terms

• Critical Illness
• Critically Ill Patients

Intervention

Behavioral:
• Virtual meeting between patients/physicians and caregiver
Virtual visits between patients-caregivers and virtual interviews between physicians-caregivers for 15minutes once a day

Locations

Country	Name	City	State
Korea, Republic of	Seoul National University Hospital	Seoul	Jongno-gu

Sponsors (1)

Lead Sponsor	Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	FS-ICU score from caregivers at discharge or 7 days after initiation of study enrolled	The FS-ICU survey score reflected the satisfaction degree of caregivers. The overall satisfaction score is derived from questions 1 through 24.	7 days